EBERHARD MAENDEL: Open Payments
NPI 1639171283 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,832 in 181 payments from 22 companies in 2025. Trend: 2023 $2,520 · 2024 $4,524 · 2025 $3,832
Food & beverage: $3,409Education: $423
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 17 | $483 |
| Janssen Biotech, Inc. | 15 | $410 |
| PFIZER INC. | 21 | $387 |
| ABBVIE INC. | 19 | $383 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 14 | $378 |
| Galderma Laboratories, L.P. | 16 | $348 |
| UCB, Inc. | 14 | $235 |
| Novartis Pharmaceuticals Corporation | 7 | $165 |
| Organon LLC | 10 | $164 |
| Amgen Inc. | 8 | $157 |
Products named: DUPIXENT, TREMFYA, CIBINQO, NEMLUVIO, Bimzelx, SKYRIZI, COSENTYX, RINVOQ.
Industry payments across NV — which companies pay providers there.
